Friday, October 30, 2026

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Jang Wonyoung’s S-Curve in Black: What You Need to Know About Her Latest Photos

IVE's Jang Wonyoung showcased her stunning visuals on Instagram, sharing a photo with the caption about knowing only certain pieces.

WORLD WAR III OR CHILD’S PLAY? Kim’s Daughter Tests Weapons That Could Erase Mankind

Kim Jong Un oversaw a test of a new rocket launcher, emphasizing its role in enhancing North Korea's nuclear deterrence strategy.

Etc

Rokit Healthcare’s AI Skin Regeneration: A Comprehensive Guide to Upcoming Innovations in China

Rokit Healthcare showcases AI-based skin regeneration technology at a local medical device fair in China, invited by the government.

How Humedix is Revolutionizing HA Fillers in Brazil: Insights from the ACE Program

Huons Group's Humedix held the ACE academic exchange program with Brazilian partners and key medical staff on October 28.

GC Biopharma Wins Approval for World’s First Intracerebroventricular Treatment for Hunter Syndrome, Bringing New Hope to Patients with Rare Diseases

GC Biopharma receives approval for the first domestic treatment for Hunter syndrome with CNS symptoms, expanding options for rare disease patients.

Ovarian Aging Breakthrough: How Stromal Hormone Production Could Revolutionize Women’s Health

A study highlighting hormone production in ovarian stromal cells during aging received an international award, promising new treatment insights.

AI in Healthcare: AITRICS Partners with Hong Kong University for VitalCare’s Clinical Validation

AITRICS, a medical AI company, collaborates with the University of Hong Kong's CHART for innovative healthcare solutions.
Latest

AI-Driven Home Patient Monitoring: How SEERS and ZeroWeb Are Revolutionizing Healthcare

SEERS expands its AI-based patient monitoring business from hospitals to homes.

How Celltrion’s Omlyclo and Aptozma Are Dominating the European Market in 2026

Celltrion expands sales of high-profit biosimilar products in the European market, continuing its growth trend.

How Wontech Plans to Dominate the Mekong Market with Innovative Beauty and Medical Devices

Wontech expands into the Mekong region from Thailand, targeting medical devices, cosmetics, and home beauty equipment.

Geo-Young Achieves Silver Medal in EcoVadis 2026 Sustainability Ratings: What This Means for the Asian Healthcare Industry

Geo-Young, Korea's largest healthcare platform, earned a Silver medal in EcoVadis' 2026 sustainability assessment, a first for a local pharmaceutical distributor.

How Inventage Labs is Transforming Antibody Delivery with Innovative Subcutaneous Injection Technology

Inventage Lab reveals key research on a drug delivery platform for high-concentration antibody and antibody-drug conjugates.

LA-GLA: The Next-Gen Fabry Disease Treatment Set for 634.7 Billion KRW Tech Export

GC Biopharma and Hanmi Pharmaceutical have jointly licensed their next-generation Fabry disease treatment candidate LA-GLA for up to 634.7 billion KRW.

How Will Budget Reductions Impact Korea’s Healthcare R&D? A Deep Dive into ARPA-H and More

Park Ji-won of the Democratic Party emphasizes the need to reassess budget cuts for healthcare R&D while maintaining goals and timelines.

Eppe: The Game-Changing Korean Weight Loss Drug You Need to Know About in 2026

Patients seek the new domestic obesity treatment Eppe, which began prescriptions in some medical institutions on October 29.

Hanlim Pharmaceutical Partners with Japan’s DCI: What This Means for the Future of Biotech in Asia

Hanlim Pharmaceutical partners with Japanese investment firm DCI Partners to explore new ventures in the pharmaceutical and biotech sectors.

Is Padoprazan the Future of GERD Treatment? Discover Its Clinical Trial Results Against Esomeprazole

Daewon Pharmaceutical's new drug Padoprazan (DW4421) shows comparable efficacy to existing treatments in domestic Phase 3 trials.

New COVID-19 mRNA Vaccine BMI2012: What You Need to Know About Its Clinical Trials

EyeGene begins Phase 1 trials for its next-gen mRNA COVID-19 vaccine, aiming for Phase 2 by next year.

SK Bioscience Launches Bundibugyo Ebola Vaccine Project with 36 Million USD U.S. Government Support

SK Bioscience will develop and produce an Ebola virus vaccine with support from the U.S. government and global research institutions.

Samsung Biologics Reports 19% Revenue Surge: What This Means for 2026 Growth

Samsung Biologics reports Q3 revenue of 1.49 trillion KRW, raising annual growth forecast to 20% due to production efficiency.

Finemedix’s Growth Strategy: Boosting International Sales with Innovative Endoscopic Products

Painmedix signs a 3 billion KRW ODM contract with Creo Medical to expand into the U.S. and Latin American markets.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.